Er-Kim Extends Exclusive Distribution Agreement with Ascendis Pharma AS to Expand Commercialization of Its Endocrinology Portfolio to Eurasian Markets
PHSBX Fund | USD 22.76 0.00 0.00% |
Slightly above 56% of Putnam Global's investor base is looking to short. The analysis of overall sentiment of trading Putnam Global Health mutual fund suggests that many investors are alarmed at this time. Putnam Global's investing sentiment can be driven by a variety of factors including economic data, Putnam Global's earnings reports, geopolitical events, and overall market trends.
Putnam |
Broadened agreement now addresses the unmet need for novel rare endocrinology disease therapies in Central and Eastern Europe and Eurasian marketsATHENS, Greece and ALMATY, Kazakhstan, Dec. 10, 2024 -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced that it has extended its exclusive agreement with Danish biopharmaceutical company Ascendis Pharma AS to commercialize three rare endocrinology
Read at finance.yahoo.com
Putnam Global Fundamental Analysis
We analyze Putnam Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Putnam Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Putnam Global based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Putnam Global is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Putnam Global Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Putnam Global mutual fund to make a market-neutral strategy. Peer analysis of Putnam Global could also be used in its relative valuation, which is a method of valuing Putnam Global by comparing valuation metrics with similar companies.
Peers
Putnam Global Related Equities
PFJAX | Putnam High | 0.18 | ||||
PFLLX | Putnam Floating | 0.12 | ||||
PFRYX | Putnam Floating | 0.12 | ||||
PFRZX | Putnam Floating | 0.12 | ||||
PFICX | Putnam Floating | 0.12 | ||||
PFRBX | Putnam Floating | 0.00 | ||||
PFLRX | Putnam Floating | 0.00 | ||||
PXMAX | Putnam Massachusetts | 0.11 | ||||
PEXTX | Putnam Tax | 0.50 | ||||
PEYAX | Putnam Equity | 0.56 |
Other Information on Investing in Putnam Mutual Fund
Putnam Global financial ratios help investors to determine whether Putnam Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Putnam with respect to the benefits of owning Putnam Global security.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |